SCHEMBL8338495

SCHEMBL8338495

CNc1ccc(S(=O)(=O)Nc2ccccc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.78
MEN1 O00255 6/20 0.78
PKM P14618 2/20 0.78
ALDH1A1 P00352 1/20 0.78
KEAP1 Q14145 2/20 0.70
IL1RN P18510 1/20 0.70
ERAP1 Q9NZ08 1/20 0.70
CA12 O43570 4/20 0.70
CA9 Q16790 4/20 0.70
CA2 P00918 3/20 0.70
CA1 P00915 2/20 0.70
GAA P10253 2/20 0.67
GFER P55789 1/20 0.59
UQCRB P14927 2/20 0.57
MAPT P10636 2/20 0.57
FFAR1 O14842 1/20 0.57
PGR P06401 1/20 0.57
HPGD P15428 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28047475 0.92 ALDH1A1 (0.63) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL9001182 0.88 KMT2A (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL28047457 0.85 LMNA (0.67) KMT2AMEN1PKMALDH1A1KEAP1
Phenyl(Phenylsulfonyl)Amine SCHEMBL114765 0.83 KEAP1 (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL810795 0.83 KMT2A (0.91) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL25031372 0.83 KEAP1 (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL27875519 0.83 ITGA1 (0.58) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL27787880 0.83 HTR6 (0.77) KMT2AMEN1ALDH1A1KEAP1CA12
SCHEMBL19119164 0.82 CA12 (1.00) KMT2AMEN1PKMALDH1A1KEAP1
SCHEMBL322990 0.82 CA12 (1.00) KMT2AMEN1PKMALDH1A1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190075798-A1 Compositions for Inhibition of Insect Sensing VANDERBILT UNIVERSITY 2019-03-14 US disclosed
US-5994398-A ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 1999-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190075798-A1 Compositions for Inhibition of Insect Sensing OR51E2, TRPA1, OR10J3 KMT2A 4243/4885MEN1 1871/4885PKM 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.